Viés de alta
$SOLY Soliton Inc continue to rally higher, more expected.
June has been a fantastic month for investors in NASDAQ:SOLY which has released numerous announcements of a very positive nature regarding pipeline products with new FDA clearance.
As of this morning it has been announced that there will be a conference call today to update investors, this could move the stock considerably.
marketwatch.com/press-release/soliton-confirms-conference-call-to-discuss-recently-announced-significant-discovery-and-fda-clearance-for-today-at-430-pm-et-2019-06-11?mod=mw_quote_news
COMPANY PROFILE
Soliton, Inc. is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm's devices generate planar acoustic waves or shock waves in cosmetic surgical procedures, aesthetic surgical procedures, and dermatology procedures for treatments. The company was founded by Walter V. Klemp & Christopher Capelli and is headquartered in Houston, TX.
As of this morning it has been announced that there will be a conference call today to update investors, this could move the stock considerably.
marketwatch.com/press-release/soliton-confirms-conference-call-to-discuss-recently-announced-significant-discovery-and-fda-clearance-for-today-at-430-pm-et-2019-06-11?mod=mw_quote_news
COMPANY PROFILE
Soliton, Inc. is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm's devices generate planar acoustic waves or shock waves in cosmetic surgical procedures, aesthetic surgical procedures, and dermatology procedures for treatments. The company was founded by Walter V. Klemp & Christopher Capelli and is headquartered in Houston, TX.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.